Stimulation of Toll-like receptor-1/2 combined with Velcade increases cytotoxicity to human multiple myeloma cells

Jahangir Abdi(California State University, Dominguez Hills), Frank A. Redegeld(Utrecht University)
Blood Cancer Journal
May 31, 2013
Cited by 13


Related Papers